Related Experiment Videos
Expression of genetic damage induced by alkylating agents in germ cells of female mice
Abstract:
The purpose of the present experiments was to analyse the frequencies of meiotic non-disjunction and structural aberrations by comparative cytogenetic investigations in unfertilized mII oocytes and first-cleavage metaphases after pre-ovulatory treatment of female mice with alkylating agents. We also present data on the expression of both types of aberration during embryogenesis in terms of dominant lethal effects. Trenimon (TR, 1 mg/kg) induced meiotic non-disjunction, but no structural aberrations were detected at metaphase II. On the contrary, at first-cleavage metaphase, TR revealed a strong clastogenic effect. A dose of 0.25 mg TR/kg increased the frequency of cells with structural aberrations to 51.79%. Mainly chromatid and a few isochromatid aberrations were found. These results support the observations previously made (see Brewen and Preston, 1979; Obe and Beek, 1979) that an intervening round of DNA replication is necessary for a TR-induced DNA lesion to be transformed into a structural aberration. The frequency of aberrant eggs in toto analysed at first cleavage (63.39%) can be quantitatively correlated to the rate of embryonic mortality (55.17%) as measured in the dominant lethal assay at the first day after treatment. We also present data on the effects of cyclophosphamide (CYC) on the first meiotic division. CYC (150 mg/kg) enhanced the incidence of meiotic non-disjunction only slightly, but induced a high frequency of dominant lethal effects (58.94%) at the first day after application.
Insights
Alkylating agents like Trenimon (TR) cause meiotic non-disjunction and structural aberrations in mouse oocytes. These genetic defects correlate with embryonic mortality, highlighting the reproductive risks of these chemicals.
Area of Science:
- Reproductive toxicology
- Cytogenetics
- Developmental biology
Background:
- Alkylating agents are known mutagens with potential reproductive toxicity.
- Understanding their effects on meiosis and early embryogenesis is crucial for risk assessment.
Purpose of the Study:
- To analyze meiotic non-disjunction and structural aberrations in mouse oocytes following exposure to alkylating agents.
- To investigate the relationship between these cytogenetic aberrations and dominant lethal effects during early embryogenesis.
Main Methods:
- Comparative cytogenetic analysis of unfertilized MII oocytes and first-cleavage metaphases in mice.
- Pre-ovulatory treatment with Trenimon (TR) and cyclophosphamide (CYC).
- Dominant lethal assay to assess embryonic mortality.
Main Results:
- Trenimon (TR) induced significant meiotic non-disjunction and a strong clastogenic effect at first cleavage, with 51.79% of cells showing structural aberrations at 0.25 mg/kg.
- A high frequency of aberrant eggs (63.39%) correlated with embryonic mortality (55.17%).
- Cyclophosphamide (CYC) showed a slight increase in meiotic non-disjunction but a high incidence of dominant lethal effects (58.94%).
Conclusions:
- Trenimon-induced DNA lesions require a round of DNA replication to form structural aberrations.
- The frequency of cytogenetic aberrations in oocytes is quantitatively linked to embryonic lethality.
- Alkylating agents pose significant risks to meiotic integrity and early embryonic development.